Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

毛霉病 医学 临床终点 两性霉素B 不利影响 内科学 外科 毛孔 临床试验 皮肤病科 抗真菌
作者
Francisco M. Marty,Luis Ostrosky‐Zeichner,Oliver A. Cornely,Kathleen M. Mullane,John R. Perfect,George R. Thompson,George Alangaden,Janice M. Brown,David N. Fredricks,Werner Heinz,Raoul Herbrecht,Н Н Климко,G. A. Klyasova,Johan Maertens,Sameer Melinkeri,Ilana Oren,Peter G. Pappas,Zdeněk Ráčil,Galia Rahav,Rodrigo Ribeiro dos Santos
出处
期刊:Lancet Infectious Diseases [Elsevier BV]
卷期号:16 (7): 828-837 被引量:629
标识
DOI:10.1016/s1473-3099(16)00071-2
摘要

Mucormycosis is an uncommon invasive fungal disease with high mortality and few treatment options. Isavuconazole is a triazole active in vitro and in animal models against moulds of the order Mucorales. We assessed the efficacy and safety of isavuconazole for treatment of mucormycosis and compared its efficacy with amphotericin B in a matched case-control analysis.In a single-arm open-label trial (VITAL study), adult patients (≥18 years) with invasive fungal disease caused by rare fungi, including mucormycosis, were recruited from 34 centres worldwide. Patients were given isavuconazole 200 mg (as its intravenous or oral water-soluble prodrug, isavuconazonium sulfate) three times daily for six doses, followed by 200 mg/day until invasive fungal disease resolution, failure, or for 180 days or more. The primary endpoint was independent data review committee-determined overall response-ie, complete or partial response (treatment success) or stable or progressive disease (treatment failure)-according to prespecified criteria. Mucormycosis cases treated with isavuconazole as primary treatment were matched with controls from the FungiScope Registry, recruited from 17 centres worldwide, who received primary amphotericin B-based treatment, and were analysed for day-42 all-cause mortality. VITAL is registered with ClinicalTrials.gov, number NCT00634049. FungiScope is registered with ClinicalTrials.gov, number NCT01731353.Within the VITAL study, from April 22, 2008, to June 21, 2013, 37 patients with mucormycosis received isavuconazole for a median of 84 days (IQR 19-179, range 2-882). By day 42, four patients (11%) had a partial response, 16 (43%) had stable invasive fungal disease, one (3%) had invasive fungal disease progression, three (8%) had missing assessments, and 13 (35%) had died. 35 patients (95%) had adverse events (28 [76%] serious). Day-42 crude all-cause mortality in seven (33%) of 21 primary-treatment isavuconazole cases was similar to 13 (39%) of 33 amphotericin B-treated matched controls (weighted all-cause mortality: 33% vs 41%; p=0·595).Isavuconazole showed activity against mucormycosis with efficacy similar to amphotericin B. Isavuconazole can be used for treatment of mucormycosis and is well tolerated.Astellas Pharma Global Development, Basilea Pharmaceutica International.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
裴帅龙关注了科研通微信公众号
1秒前
1秒前
天天快乐应助Lin采纳,获得10
1秒前
金元宝发布了新的文献求助10
2秒前
DM发布了新的文献求助10
2秒前
2秒前
博弈春秋发布了新的文献求助10
2秒前
3秒前
桐桐应助琉璃果冻采纳,获得30
3秒前
3秒前
桔梗发布了新的文献求助10
4秒前
4秒前
4秒前
阳小颖完成签到,获得积分10
4秒前
万能图书馆应助Wendyya采纳,获得10
5秒前
6秒前
牛X发布了新的文献求助10
7秒前
南瓜汤完成签到,获得积分10
7秒前
7秒前
奋斗瑶完成签到,获得积分10
8秒前
对方正在输入关注了科研通微信公众号
8秒前
qaz发布了新的文献求助10
8秒前
8秒前
CSPC001发布了新的文献求助10
9秒前
9秒前
每天都是好时光完成签到 ,获得积分10
10秒前
王淳发布了新的文献求助10
10秒前
10秒前
重要的念文完成签到,获得积分10
11秒前
一骑绝尘发布了新的文献求助10
11秒前
IvanLing发布了新的文献求助10
11秒前
cc发布了新的文献求助10
12秒前
机智谷蕊发布了新的文献求助10
12秒前
李健的小迷弟应助sch采纳,获得10
13秒前
福路路发布了新的文献求助30
13秒前
乖猫要努力应助元谷雪采纳,获得10
14秒前
14秒前
852应助泡菜汤味豆腐采纳,获得10
14秒前
哈哈哈哈完成签到,获得积分10
15秒前
mmc发布了新的文献求助10
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971277
求助须知:如何正确求助?哪些是违规求助? 3515939
关于积分的说明 11180280
捐赠科研通 3251061
什么是DOI,文献DOI怎么找? 1795664
邀请新用户注册赠送积分活动 875937
科研通“疑难数据库(出版商)”最低求助积分说明 805209